
DRAP Reviews Drug Pricing Formula As Minister Rejects Unjustified Price Increases
Officials said case-by-case evaluation of pending pricing cases is nearly complete, while DRAP is examining rules that may affect fair price determination and confirmed adequate supplies of the WHO-recommended trivalent flu vaccine.

_20260126115701440_af4631%20(3)_20260914115350308_11eb60.webp)





















































.png)


















_20260918164710348_1a4e19.webp)


